News Release

<< Back

Surmodics to Webcast Second Quarter 2016 Earnings Conference Call on May 2

Webcast is Live at 4 p.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Apr. 28, 2016-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2016 conference call on Monday, May 2, at 4 p.m. CT (5 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon.

Gary Maharaj, president and chief executive officer, and Andy LaFrence, vice president of finance and chief financial officer, will recap the second quarter 2016 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at www.surmodics.com the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 7 p.m. CT on Monday, May 2, until 7 p.m. CT on Monday, May 9, by registering for the replay at https://jsp.premiereglobal.com/webrsvp using replay passcode 8501461. In addition, the conference call audio and transcript will be archived on the Company’s website following the call.

About Surmodics, Inc.

Surmodics is known as the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) tests and microarrays. Following two recent acquisitions of Creagh Medical and NorMedix, the company is executing on a key growth strategy for its medical device business by expanding to offer total intravascular product solutions to its medical device customers. The combination of proprietary surface technologies, along with enhanced device design, development and manufacturing capabilities, enables Surmodics to significantly increase the value it offers with highly differentiated intravascular solutions designed and engineered to the most demanding requirements. With this focus on offering total solutions, Surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges. Surmodics is headquartered in Eden Prairie, Minnesota. For more information about the company, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

Source: m, Inc.

Surmodics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com